- Nam-Gu Her, AimedBio’s Head of R&D, gives a speech on ‘Introduction to Aimedbio’s patient-centric AI novel drug therapeutics development
and precision medicine’
at BIOKOREA 2022.
- AimedBio uses patient big data and patient-derived samples to develop novel antibody-based therapeutics with high speed and accuracy.